Evidence map›Paper›PMID 23702006›Full record

Trial reportTrials2013

Transfusion requirements in septic shock (TRISS) trial - comparing the effects and safety of liberal versus restrictive red blood cell transfusion in septic shock patients in the ICU: protocol for a randomised controlled trial.

Lars B Holst, Nicolai Haase, Jørn Wetterslev, Jan Wernerman, Anders Aneman, Anne B Guttormsen, Pär I Johansson, Sari Karlsson, Gudmundur Klemenzson, Robert Winding and 37 more

2 registry-linked trialsOpen access · goldAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Trials, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01485315 phase3completednot on this map

Effects of Red Blood Cell Transfusion on Mortality and Morbidity in Patients With Septic Shock

TypeinterventionalSponsorScandinavian Critical Care Trials GroupRan2011 to 2014Enrolled1,005ConditionsSeptic ShockArmsSAGM (Saline-Adenine-Glucose-Mannitol) blood transfusion
NCT06560164 narecruitingnot on this mapstarted 2024, after this paper: background citation

Restrictive Versus Liberal Thresholds for Red Blood Cell Transfusion in ExtraCorporeal Membrane Oxygenation - the TREC Study

TypeinterventionalSponsorAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Ran2024 to 2028Enrolled526ConditionsTransfusion, Red Blood Cell, Extracorporeal Membrane Oxygenation, AnemiaArmsRed Blood Cell transfusion
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 46 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Observational
  7. Observational
  8. Comment on Debate: Blood is Friend or/and Foe?Turkish journal of anaesthesiology and reanimation · 2018
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Testing current practice is no mistake.Intensive care medicine · 2015
    Article
  17. Effect of ERK1/2 signaling pathway in electro-acupuncture mediated up-regulation of heme oxygenase-1 in lungs of rabbits with endotoxic shock.Medical science monitor : international medical journal of experimental and clinical research · 2014
    Article
  18. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

47 authors at 20 institutions in 6 countries.

Lars B HolstDepartment of Intensive Care, Copenhagen University Hospital, Rigshospitalet, Denmark. Lars.Broksoe.Holst@regionh.dk
Nicolai Haase
Jørn Wetterslev
Jan Wernerman
Anders Aneman
Anne B Guttormsen
Pär I Johansson
Sari Karlsson
Gudmundur Klemenzson
Robert Winding
Lars Nebrich
Carsten Albeck
Marianne L Vang
Hans-Henrik Bülow
Jeanie M Elkjær
Jane S Nielsen
Peter Kirkegaard
Helle Nibro
Anne Lindhardt
Ditte Strange
Katrin Thormar
Lone M Poulsen
Pawel Berezowicz
Per M Bådstøløkken
Kristian Strand
Maria Cronhjort
Elsebeth Haunstrup
Omar Rian
Anders Oldner
Asger Bendtsen
Susanne Iversen
Jørn-Åge Langva
Rasmus B Johansen
Niklas Nielsen
Ville Pettilä
Matti Reinikainen
Dorte Keld
Siv Leivdal
Jan-Michael Breider
Inga Tjäder
Nanna Reiter
Ulf Gøttrup
Jonathan White
Jørgen Wiis
Lasse Høgh Andersen
Morten Steensen
Anders Perner
Copenhagen University Hospital · DKRigshospitalet · DKBispebjerg Hospital · DKKarolinska University Hospital · SEAarhus University Hospital · DKÅlesund Hospital · NOHolbæk Sygehus · DKHvidovre Hospital · DKRegional Hospital Horsens · DKSlagelse Hospital · DKCentrallasarettet Växjö · SEGentofte Hospital · DKGlostrup Hospital · DKHaukeland University Hospital · NOHelsingborgs lasarett · SEHelsinki University Hospital · FIKolding Hospital · DKLiverpool Hospital · AUNæstved Sygehus · DKNational University Hospital of Iceland · IS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTransfusion of red blood cells (RBC) is recommended in septic shock and the majority of these patients receive RBC transfusion in the intensive care unit (ICU). However, benefit and harm of RBCs have not been established in this group of high-risk patients. METHODS/

designThe Transfusion Requirements in Septic Shock (TRISS) trial is a multicenter trial with assessor-blinded outcome assessment, randomising 1,000 patients with septic shock in 30 Scandinavian ICUs to receive transfusion with pre-storage leuko-depleted RBC suspended in saline-adenine-glucose and mannitol (SAGM) at haemoglobin level (Hb) of 7 g/dl or 9 g/dl, stratified by the presence of haematological malignancy and centre. The primary outcome measure is 90-day mortality. Secondary outcome measures are organ failure, ischaemic events, severe adverse reactions (SARs: anaphylactic reaction, acute haemolytic reaction and transfusion-related circulatory overload, and acute lung injury) and mortality at 28 days, 6 months and 1 year.The sample size will enable us to detect a 9% absolute difference in 90-day mortality assuming a 45% event rate with a type 1 error rate of 5% and power of 80%. An interim analysis will be performed after 500 patients, and the Data Monitoring and Safety Committee will recommend the trial be stopped if a group difference in 90-day mortality with P ≤0.001 is present at this point. DISCUSSION: The TRISS trial may bridge the gap between clinical practice and the lack of efficacy and safety data on RBC transfusion in septic shock patients. The effect of restrictive versus liberal RBC transfusion strategy on mortality, organ failure, ischaemic events and SARs will be evaluated.

Indexed as

Intensive Care UnitsResearch DesignBiomarkersClinical ProtocolsClinical Trials Data Monitoring CommitteesErythrocyte TransfusionFluid TherapyHemoglobinsHumansIcelandRisk AssessmentRisk FactorsScandinavian and Nordic CountriesShock, SepticTime FactorsTreatment OutcomeBiomarkersHemoglobins

Identifiers

PMID23702006
PMCPMC3679866
OpenAlexW2149526552

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.